PortfoliosLab logo

iShares U.S. Pharmaceuticals ETF

IHE
ETF · Currency in USD
ISIN
US4642888360
CUSIP
464288836
Issuer
iShares
Inception Date
May 5, 2006
Region
North America (U.S.)
Category
Health & Biotech Equities
Expense Ratio
0.42%
Index Tracked
Dow Jones U.S. Select Pharmaceuticals Index
ETF Home Page
www.ishares.com
Asset Class
Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

IHEPrice Chart


Chart placeholderClick Calculate to get results
S&P 500

IHEPerformance

The chart shows the growth of $10,000 invested in iShares U.S. Pharmaceuticals ETF on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $37,202 for a total return of roughly 272.02%. All prices are adjusted for splits and dividends.


IHE (iShares U.S. Pharmaceuticals ETF)
Benchmark (S&P 500)

IHEReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-1.27%
6M4.65%
YTD4.07%
1Y10.47%
5Y6.71%
10Y11.97%

IHEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

IHESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current iShares U.S. Pharmaceuticals ETF Sharpe ratio is 0.81. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


IHE (iShares U.S. Pharmaceuticals ETF)
Benchmark (S&P 500)

IHEDividends

iShares U.S. Pharmaceuticals ETF granted a 1.47% dividend yield in the last twelve months, as of Oct 16, 2021. The annual payout for that period amounted to $2.71 per share.


PeriodTTM20202019201820172016201520142013201220112010
Dividend$2.71$2.14$2.24$1.77$2.10$1.30$3.11$1.82$1.25$1.67$0.90$0.89

Dividend yield

1.47%1.19%1.40%1.25%1.36%0.92%1.93%1.20%1.06%1.97%1.18%1.39%

IHEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


IHE (iShares U.S. Pharmaceuticals ETF)
Benchmark (S&P 500)

IHEWorst Drawdowns

The table below shows the maximum drawdowns of the iShares U.S. Pharmaceuticals ETF. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the iShares U.S. Pharmaceuticals ETF is 32.24%, recorded on Mar 23, 2020. It took 140 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-32.24%Jul 17, 20151179Mar 23, 2020140Oct 9, 20201319
-16.88%Jul 8, 201122Aug 8, 201194Dec 20, 2011116
-11.32%Mar 24, 201053Jun 8, 201072Sep 20, 2010125
-10.43%Mar 5, 201429Apr 14, 201446Jun 19, 201475
-10.39%Oct 18, 201219Nov 15, 201252Feb 1, 201371
-7.82%Jan 26, 202127Mar 4, 202154May 20, 202181
-7.8%Aug 18, 202133Oct 4, 2021
-7.74%Jul 7, 201424Aug 7, 201418Sep 3, 201442
-7.62%Oct 13, 202014Oct 30, 20207Nov 10, 202021
-7.24%Jan 20, 201014Feb 8, 201030Mar 23, 201044

IHEVolatility Chart

Current iShares U.S. Pharmaceuticals ETF volatility is 9.29%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


IHE (iShares U.S. Pharmaceuticals ETF)
Benchmark (S&P 500)

Portfolios with iShares U.S. Pharmaceuticals ETF


Loading data...

More Tools for iShares U.S. Pharmaceuticals ETF